Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0001373604-24-000114·Atea Pharmaceuticals, Inc.
Schedule 13D ownership disclosure
Atea Pharmaceuticals Inc
Common Stock, par value $0.001 per share · CUSIP: 04683R106
Event date: 2024-12-13
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- BML Investment Partners, L.P.Reported CIK 0001373604
Shares: 6,808,312 · Class: 8.1%
- Leonard Braden MichaelReported CIK 0001373603
Shares: 7,216,312 · Class: 8.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001373604-24-000114
- Form type
- SCHEDULE 13D
- Filer
- Atea Pharmaceuticals, Inc.
- CIK
- CIK 1593899
- Filed
- Dec 16, 2024
- Reporting period
- Dec 13, 2024
- Description
- Schedule 13D beneficial ownership